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Abstract
Parasitic infections are likely under-recognized among immigrant populations in the USA. We conducted a cross-sectional study
to evaluate if such infections have health impacts among recent immigrants in Chicago and to identify predictive factors for
parasitic infections. A total of 133 recent immigrants were enrolled, filling out a standardized medical questionnaire and
providing blood and stool samples. Appriximately 12% of subjects (15/125) who provided a blood or stool sample for testing
were found to have evidence of current or prior infection with a pathogenic parasite, of which Toxocara spp. (8 subjects, 6.4%)
and Strongyloides stercoralis (5 subjects, 4%) were most commonly identified. Parasitic infection was more likely among
subjects who had immigrated within the previous 2 years and those with a self-reported history of worms in the stool. The most
useful surrogate markers identified for parasitic infections were an elevated immunoglobulin E level (seen in 46.7% (7/15) of
subjects with parasitic infections and 20% (22/110) of uninfected individuals, p = 0.04) and the presence of Blastocystis hominis
cysts on Ova & Parasite exam (detected in 38.5% (5/13) of subjects with parasitic infections who provided a stool sample and
5.1% (5/98) of uninfected subjects, p = 0.002). Our study found that parasitic infections may be common in recent US immigrants, which highlights an important health disparity among a vulnerable population that merits further study. Additionally,
clinical risk factors, symptoms, and laboratory findings traditionally thought to be associated with parasites were commonly
found but not predictive of infection in this study population.
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Introduction
Among select populations within the USA, parasitic diseases
are thought to be an under-recognized public health problem
(Garg et al. 2005; Hotez 2007; Hotez 2008; Hotez 2014;
Hotez et al. 2012; Jariwala et al. 2017; Parise et al. 2014).
Although exact numbers are not available, studies have suggested that within the USA there may be up to 300,000 people
with Chagas disease (Bern et al. 2011; Bern and Montgomery
2009; Leiby et al. 2002; Manne-Goehler et al. 2016; Sarkar
et al. 2010; Schmunis and Yadon 2010; Zaniello et al. 2012),
1.3–2.8 million with serological evidence of exposure to
Toxocara spp. (Hotez 2008; Liu et al. 2018), 4 million with
soil-transmitted helminths (Hotez 2008; Posey et al. 2007;
Safdar et al. 2004), 1.2 million with giardiasis (Adams et al.
2017), 41,400–169,000 with cysticercosis (Hotez 2008), and
approximately 8000 with schistosomiasis (Hotez 2008).
US immigrant populations are believed to be at increased
risk for parasitic infections, as many immigrants come from
areas where some parasites are endemic (Arena et al. 2011;
Hotez 2008; Meymandi et al. 2017; Ostera and Blum 2016;
Ostera et al. 2017). Whereas refugees to the USA undergo
thorough screening coupled with treatment of infectious diseases prior to arrival, legal immigrants (who may have similar
risk factors as refugees) are only required to undergo screening for infectious diseases of significant public health importance, such as tuberculosis. As would be expected, illegal
immigrants are not screened for any infections. Upon arrival
to the USA, immigrants may be more likely to have a decreased socioeconomic status and therefore frequently reside
in the underserved areas within the USA (characterized by
increased poverty rates, impaired access to healthcare, and a
high percentage of households with suboptimal plumbing)
that are thought to have an increased prevalence of parasitic
infections (Hotez 2007; Hotez 2008; Hotez 2014; McKenna
et al. 2017). This population thus possesses a dual risk for
parasites, either acquired from their country of origin or following emigration to the USA (Parise et al. 2014). However,
published prevalence estimates vary widely, and there is little
data regarding the current impact of these infections in the
USA.
Both diagnostic and methodologic problems have impeded
research regarding parasitic infections among US immigrants.
Diagnostic inaccuracies can occur because laboratory tests for
parasites can have significant limitations including poor sensitivities and lack of availability in the community (BelhassenGarcia et al. 2014; Hotez 2014; Jariwala et al. 2017; Ostera
and Blum 2016; Parise et al. 2014; Posey et al. 2007; Shulman
et al. 1997). Further, the primary method of diagnosis for
many parasitic infections, serologic testing, has several important shortcomings, including an inability to distinguish between active and past infections, cross-reactivity between different parasites, and in many cases a reduced sensitivity due to

the focal nature of some parasitic diseases (Khurana and Sethi
2017; Maddison 1991; Ndao 2009). Methodologic limitations
to research studies may also partly account for these widely
varying prevalence estimates (Garg et al. 2005; Hotez 2008;
Hotez 2014). For example, past estimates of Chagas disease
prevalence were based on testing of blood donors, which has
been shown to underestimate the number of infected individuals (Bern et al. 2008). A second commonly used method
creates an estimate based on the number of immigrants living
in the USA and disease prevalence in endemic regions.
However, infection risks among those who emigrated may
be different from that of the general population within a given
country (Arena et al. 2011; Bern and Montgomery 2009;
Conners et al. 2016; Crum et al. 2003; Perez-Molina et al.
2012; Schmunis and Yadon 2010).
Many of the published studies evaluating health impacts of
parasitic infections on immigrants either screened for only a
small number of parasites or screened immigrants from a single
country (Bern et al. 2011; Bern and Montgomery 2009; Ostera
and Blum 2016; Ostera et al. 2017; Rapoport et al. 2015; Sarkar
et al. 2010; Won et al. 2008; Zaniello et al. 2012). Improved
data regarding these health impacts is badly needed as parasitic
infections can have significant morbidity (Fitzpatrick et al.
2010; Hotez 2007; Hotez 2008; Hotez et al. 2012; Jariwala
et al. 2017; Parise et al. 2014; Posey et al. 2007; Starr and
Montgomery 2011). For example, Chagas disease causes cardiomyopathy and/or esophageal or colonic dilation in up to 20–
30% of those infected (Bern et al. 2011; Moncayo and Ortiz
Yanine 2006); those with toxocariasis may have an increased
risk for asthma (Buijs et al. 1997; Cobzaru et al. 2012;
Kanobana et al. 2013; Walsh 2011); and intestinal parasite infection has been associated with delayed cognitive development and impaired nutrition in some studies (Ezeamama et al.
2005; Yap et al. 2012). Parasitic infections have also been
shown to increase the severity of illnesses due to other infectious diseases such as tuberculosis and HIV (Garg et al. 2005).
This study was conducted with the overall aim of assessing
if parasitic infections are a significant health problem among
recent immigrants, as currently there are few studies that have
addressed this question. As many of the symptoms of parasitic
infections are nonspecific, an additional objective of our study
was to identify if there are symptoms, signs, or laboratory tests
that could be used in this population as predictors of the presence of parasites.

Materials and methods
Compliance with ethical standards The study was approved
by the Institutional Review Board of the University of Illinois
at Chicago, and written informed consent was obtained from
all participants. For Spanish-speaking individuals, consent
was obtained using consent and/or assent forms translated into
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Study design Patients were enrolled for this cross-sectional
study between November 2014 and July 2016. Subjects were
recruited through collaboration with local community organizations that provide services to immigrants and through a
mass email sent to students enrolled at the University of
Illinois at Chicago. Subjects were also recruited from community health clinics as long as they were accessing the
healthcare system for reasons clearly unrelated to a parasitic
infection (e.g., patients presenting for routine physical exams).
Subjects were eligible for inclusion if they were ages 10–80
and an immigrant living in the US mainland for less than
5 years and were originally from Africa, Asia, South
America, Central America, Mexico, the Caribbean islands,
or Puerto Rico. Although they are US citizens and not immigrants from non-US territories, Puerto Ricans were specifically included in this study because previous research suggested
that parasitic infections were common among the Puerto
Rican population in Chicago (Winsberg et al. 1975). The 5year time point for living in the USA was chosen based on the
average expected life-span of hookworms, Ascaris
lumbricoides, and Trichuris trichiura, a primary focus of our
investigations (Jourdan et al. 2017). Subjects were excluded
from the study if they (1) were currently pregnant, as the
immunosuppression of pregnancy may alter the presentation
and one of the aims of the study was to identify factors predictive of parasitosis, or (2) had taken antiparasitic medications since moving to the continental USA.
Upon enrollment, a standardized questionnaire (Online
Resource – Supplemental Appendix) was administered to collect information regarding demographics, risk factors for parasitic infections, and symptoms. Participants then provided
clinical samples to be tested for evidence of parasitic infections as described below.

ImmunoCAP® Fluorescent Enzyme Immunoassay, Arup
Laboratories, Salt Lake City, UT). The remainder of the supernatant was stored at − 80 °C until samples were shipped as
a batch to the Centers for Disease Control and Prevention,
where serologic testing was performed for infections endemic
to each subject’s country of origin (Online Resource Table 1).
Antibody responses to cysticercosis, strongyloidiasis, and
toxocariasis were determined using a multiplex bead-based
assay, MBA (Anderson et al. 2015; Hernandez-Gonzalez
et al. 2017; Rascoe et al. 2015). For cysticercosis, three recombinant antigens (rGP50, rT24H, and sTs18var1) were
used; one recombinant antigen was used for both strongyloidiasis (Ss-NIE-1) and toxocariasis (rTc-CTL-1). The assays
were conducted and interpreted according to previously published methods (Anderson et al. 2015; Hernandez-Gonzalez
et al. 2017; Rascoe et al. 2015).
Antibody against T. cruzi antigens was detected using a
commercial kit (Weiner Lab, Argentina) and by following
the company protocol instructions (Affranchino et al. 1989;
Chagatest: ELISA recombinante v. 3.0. Rosario n.d.; da
Silveira et al. 2001). All serum specimens were initially tested
by FAST-ELISA using Schistosoma mansoni adult microsomal antigen and then by a species-specific immunoblot appropriate to the subject’s country of origin according to previously published methods (Hancock and Tsang 1986; Tsang and
Wilkins 1991; Tsang and Wilkins 1997).
Patients also provided a stool sample for standard Ova &
Parasite (O&P) direct microscopy (Arup Labs Qualitative
Concentration/Trichrome Stain/Microscopy, Salt Lake City,
UT) and a multi-parallel quantitative polymerase chain reaction (qPCR) which tests for eight common gastrointestinal
pathogens (Ancylostoma, Ascaris, Cryptosporidium,
Entamoeba, Giardia, Necator, Strongyloides, and Trichuris).
Only one stool sample was requested for O&P due to our
desire to compare O&P directly with qPCR and because the
yield of collecting multiple samples for O&P exam for any
new identifiable pathogens has been shown to be low in immigrant populations (Bass et al. 1992). The stool samples for
qPCR were frozen without fixatives at −80 °C and shipped as
a batch to the Baylor College of Medicine where the DNA was
extracted using the MP FastDNA for Soil Kit (MP
Biomedicals, Solon, OH) and qPCR were conducted according to previously published methods (Cimino et al. 2015;
Mejia et al. 2013; Weatherhead et al. 2017).

Laboratory testing Whole blood for a complete blood count
was collected in an ethylenediaminetetraacetic acid (EDTA)
tube and processed in the clinical laboratory at the University
of Illinois at Chicago (BXH 800 or BXH 1600, Beckman
Coulter, Brea, CA) within 12 h. Serum samples were collected
in a serum separator tube (SST) and centrifuged within 1 h of
collection. A portion of the supernatant was sent for measurement of immunoglobulin E (IgE) level (Quantitative

Statistical analysis Statistical analyses were performed using
Prism 7 (GraphPad, San Francisco, CA) and SAS (Cary, NC).
Data were summarized by using frequency with percentage
for categorical variables. For continuous variables, geometric
mean with standard deviation or median with range or interquartile range was used. For categorical variables, prevalence
ratios (PR) were used to evaluate relationships between covariates and the main outcome (the presence of a parasitic

Spanish. Subjects who spoke languages other than English or
Spanish had the consent form explained to them in their language of preference (using an interpreter). For enrolled individuals between the ages of 10 and 18, the subject signed an
assent form, and a parent or guardian signed a parental permission form. Each participant received $40 to compensate
them for their time. Treatment for parasitic infections was
not a part of the study, but all subjects were offered the possibility of seeing one of the study authors (JH) in clinic free of
charge to discuss treatment options.
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infection), and Fisher’s exact test or chi-squared test were used
to determine significance. Mann-Whitney U test was used to
evaluate for associations between continuous variables and
the presence of a parasite. Correlations were calculated using
Spearman’s rank correlation coefficient. Kappa values were
used to compare results from stool O&P exam to qPCR
testing.

Results
Patient characteristics Seven hundred and thirty-eight people
were approached about the study, and 133 were enrolled
(Online Resource Fig. 1). All enrolled subjects filled out the
study questionnaire (unedited results shown in Online
Resource Table 2); 94% of enrolled subjects (125/133) provided blood, and 85% (113/133) provided stool samples for
testing. The mean age of enrolled subjects was 32 years, and
45.1% (60/133) were male (Table 1). Participants came from
28 different countries. As shown in Table 1, many subjects
reported having been exposed to risk factors for parasitic
infection.
Laboratory testing The median IgE among the 125 subjects
from whom blood samples were obtained was 57 IU/mL
(range 3–7732), and 23.2% of subjects (29/125) had elevated
IgE levels. Twelve subjects (9.8%) were found to have eosinophilia, and the median absolute eosinophil count (AEC) level
was 200 cells/UL (range 0–1600 cells/UL, Table 1).
Parasitic infections Twelve percent (15/125) of subjects who
provided a clinical sample for testing were found to have
evidence of current or prior infection with a pathogenic parasite species. As shown in Table 2, the most common infections
identified were Toxocara spp., seen in eight subjects (6.4%),
followed by S. stercoralis (five subjects, 4%, Table 2).
Outcome assessment There were no significant differences in
symptoms, exposures, or laboratory results between those
found to be mono-infected with each of the different parasite
species detected. Consequently, for our primary analysis, we
compared uninfected individuals to subjects with evidence for
any pathogenic parasitic infection with infected subjects treated as a single group.
A large number of subjects (10/111 subjects who provided
a sample for O&P testing, 9%) were found to have B. hominis.
Although the pathogenicity of B. hominis remains controversial (Andersen and Stensvold 2016; Roberts et al. 2014), infection with this organism in our sample was not associated
with any significant differences in symptoms or laboratory
values compared to the uninfected group. Accordingly, in
our analysis B. hominis was not included as a pathogenic
parasitic infection.
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Demographic characteristics and exposure histories of subjects with parasitic infections Nearly all of the subjects
found to have evidence of a pathogenic parasite (14/15,
93.3%) had lived in the continental USA for 2 years or
less (compared to 70/110 of those who were uninfected,
63.6%, PR 6.8, p = 0.02, Table 3). This history was therefore a very sensitive, though not specific, marker for parasitic infections (sensitivity 93.3%, specificity 36.4%,
PPV 16.7%, NPV 97.6%). No other demographic variables, including age, gender, recruitment site, or region
of origin differed significantly between those with and
without infections (Online Resource Table 3).
A self-reported history of ever having seen worms in the
stool was also associated with evidence of current or prior
parasitic infection (8/15, 53.3% in the infected group reported
this history versus 18/110, 16.4%, in the uninfected group,
p = 0.003, PR 4.4, Table 3). This history appeared to be a
nonspecific marker and was equally common among those
diagnosed with enteric parasites compared to those with
non-enteric parasites (p value = 0.8). Other classic risk factors
for parasitic infections (close contact with animals, etc.), although commonly reported among study participants, did not
differ between groups (all p values > 0.05, Online Resource
Table 3).
In the year prior to study enrollment, subjects with evidence of parasitic infections had experienced an overall increased number of physical complaints (median 8) compared
to those with no evidence of parasites (4, p = 0.02). However,
symptoms typically thought of as indicative of parasitic infections (rash, pruritus, etc.) did not differ significantly between
the groups (all p values > 0.05 for symptoms experienced both
the day of study enrollment and within the previous year,
Online Resource Table 3).
Laboratory values in subjects with evidence of parasitic infections Both the median IgE level (249 IU/mL) and the proportion of subjects with an increased IgE level (7 of 15 subjects,
46.7%) were significantly increased in subjects with evidence
for parasitic infections compared to those who were uninfected (median IgE 52 IU/mL, 22/110, 20%, subjects with elevated IgE level, both p values < 0.05, Table 3 and Online
Resource Table 4). Increases in IgE were not associated with
a history of seasonal allergies and/or asthma (all p values =
NS). The difference in median IgE levels between groups
remained statistically significant when subjects < 18 years
old were excluded from analysis (as normal values for IgE
are higher in this group). Although an elevated IgE level
was a relatively specific finding for parasitic infections (specificity 80%, NPV 92%), this finding was not a sensitive marker of infection (sensitivity 47%, PPV 24%).
The median AEC did not differ between those with and
without evidence of a parasitic infection (Online Resource
Table 4). Despite a low sensitivity for parasites (20%, PPV

Parasitol Res (2020) 119:1139–1148
Table 1
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Demographics, symptoms, and laboratory results of 133 enrolled subjects

Characteristic

Resultsa

Age, mean years (standard deviation)
Gender, male/female, N (% male)
Country/region of origin, N (%)
Asia (excluding India)
Mexico
India
Central/South America
Africa
Middle East
USA (Puerto Rico)b
Mean number of years in school (standard deviation)
Annual household income in US dollars, N (%)
< 20,000
20,000–40,000
40,000–60,000
60,000–100,000
> 100,000
Length of time living in the continental USAc, mean years
(range, standard deviation in years)
Raised in rural environment, N (%)
Exposure history prior to immigration, number yes (%)
Frequently walked barefoot
Close contact with animals
Used a well as source of drinking water
Bathed in streams or ponds
Lived in a house with a thatched roof
Treatment with antiparasitic medication prior to emigration, number yes (%)
Symptoms reported by the patient on the day of study enrollmentd, N (%)
Gastrointestinal
Constitutional
Musculoskeletal
Dermatologic
Pulmonary
Cardiovascular
Allergic
Immunoglobulin E (IgE) results
Subjects with elevated Immunoglobulin E, N (%)
Immunoglobulin E level, IU/mL, median (range, standard deviation)
Absolute eosinophil count (AEC) results
Subjects with elevated absolute eosinophil count, N (%)
Absolute eosinophil count, median cells/μl (range, standard deviation)
Pathogenic parasitic infection, N (%)

32 (17.3)
60:73 (45.1)

a

33 (24.8)
30 (22.6)
26 (19.5)
22 (16.5)
13 (9.8)
5 (3.8)
4 (3)
9.9 (5.2)
95 (71.4)
30 (22.6)
5 (3.8)
2 (1.5)
1 (0.8)
2 (10 days–5 years, 1.6)
25 (18.8)
76 (57.1)
65 (48.9)
65 (48.9)
58 (43.6)
25 (18.8)
46 (34.6)
32 (24.1)
25 (18.8)
25 (18.8)
13 (9.8)
12 (9)
10 (7.5)
3 (2.3)
29/125e (23.2)
57 (3–7732, 706)
12/123f (9.8)
200 (0–1600, 240)
15/125g (12)

Unedited results from all enrolled subjects are shown in Online Resource Table 2; N number of subjects

b

Although they are US citizens and not immigrants from non-US territories, Puerto Ricans were specifically included in this study because previous
research suggested that parasitic infections were common among the Puerto Rican population in Chicago

c

Potential range (due to enrollment criteria) 0–5 years

d

Gastrointestinal symptoms included heartburn, difficulty or pain with swallowing, abdominal pain, diarrhea, and nausea/vomiting; constitutional
symptoms included weight loss, fatigue, fevers, and weakness; musculoskeletal symptoms included pain and stiffness in the joints or myalgias;
dermatologic included itching, hives, or rash; pulmonary symptoms included wheezing, shortness of breath, and cough; cardiovascular included chest
pain, palpitations, or irregular heart beat; and allergic symptoms included those who responded “yes” to the question “do you currently have any
symptoms of seasonal allergies”
e
Of the 125 subjects who underwent a blood draw, normal value of IgE defined as < 696 IU/mL for subjects 10–12 years old, < 629 for those ages 13–15,
< 537 for those ages 16–17, and < 214 IU/mL in adults
f

For two of the 125 subjects who underwent a blood draw, a complete blood count was unable to be performed due to clotting of the blood sample,
normal AEC defined as < 500 cells/UL
g

Of 125 subjects who provided a clinical sample (blood or stool) for testing

25%), however, eosinophilia was relatively specific to subjects with evidence of parasitic infection (specificity 91.8%,
NPV 89.4%).

The presence of cysts of B. hominis on O&P exam was
strongly associated with an increased likelihood for infection
with a pathogenic parasite species. About 39% (5/13) of

Parasitol Res (2020) 119:1139–1148
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Table 2

Parasitic infections diagnosed among recent immigrants living in Chicago

Parasitic infections
Soil-transmitted helminths
Toxocara spp.
Strongyloides stercoralis
Trichuris trichiura
Ascaris lumbricoides
Protozoa
Giardia duodenalis
Nonpathogenic or disputed pathogenicity speciese
Blastocystis hominis
Endolimax nana
Dientamoeba fragilis
Iodamoeba bütschlii, Entamoeba coli, Entamoeba hartmanni
Number of subjects with multiple pathogens
Comparison of Ova & Parasite Exam to qPCR for pathogenic speciesg
Ova & Parasite positive
Ova & Parasite negative
a

Number of subjects infected (%)

8 (6.4)a
5 (4)b
2 (1.8)c
1 (0.9)c
4 (3.5)d
10 (9)
4 (3.6)
3 (2.7)
1 each (0.9)
3 (2.4)f
qPCR positive
1
7

qPCR negative
0
107

Of 125 subjects who provided blood samples for testing, all 8 subjects were diagnosed based on a positive serologic test

b

Of 125 subjects who provided blood and/or stool samples for testing, 1 subject tested negative on O&P but positive on both serology and stool qPCR, 3
subjects had a positive serologic test but negative O&P and qPCR, and 1 subject had a positive serology but did not provide a stool sample for testing
c

Diagnosed based on a positive stool qPCR test, of 113 subjects who provided a stool sample for qPCR testing

d

Of 113 subjects who provided a stool sample for testing, 1 subject tested positive on both qPCR and O&P tests, and 3 subjects tested positive on qPCR
but negative on O&P
e

Of 111 subjects who returned a stool sample for O&P testing, all infections diagnosed based on a positive on O&P exam as these nonpathogenic or
disputed pathogenicity organisms were not tested for on qPCR

f
Of 125 subjects who provided blood and/or stool samples for testing, one subject had positive stool qPCR tests for both Ascaris and Trichuris and a
positive serologic test for Toxocara, 1 subject had positive stool qPCR tests for Trichuris and Giardia as well as positive serologic testing for Toxocara,
and the third subject had positive serologic testing and stool qPCR for S. stercoralis and positive serologic testing for Toxocara
g
p value = 0.07, sensitivity of O&P compared to qPCR 12.5%, specificity 100%, positive predictive value (PPV) 100%, negative predictive value (NPV)
93.9%, kappa 0.21

subjects in the parasite positive group who returned a stool
sample had a positive O&P for Blastocystis, compared to 5%
(5/98) tested for O&P exam in the uninfected group (p =
0.002, PR = 6.3, Table 3).

Discussion
Despite the fact that many US immigrants come from areas
where parasitic infections are endemic, it is not known if these
infections are currently an important health issue among immigrant populations. In response to this deficit, we conducted
a comprehensive evaluation for the presence of a broad array
of parasitic infections in recent immigrants in Chicago. We
found that 12% of recent immigrants in our sample had evidence of prior or current infection with a pathogenic parasite
species.
Although limited by the small number of subjects found to
have evidence of parasitic infection, our study still identified a
few key factors which were significantly more likely in

subjects with evidence of parasites: a self-reported history of
having previously observed worms in the stool, having immigrated within the past 2 years, and reporting a relatively high
number of nonspecific physical ailments within the previous
year. Our results also highlight that clinical risk factors (contact with animals and frequently walking barefoot), symptoms
(including urticaria, rash, and diarrhea), and laboratory findings (eosinophilia) traditionally thought to be associated with
parasites were commonly found but not predictive of infection
in this study population. If confirmed in a larger sample, these
results suggest that practitioners should have a high degree of
suspicion for parasitic infections when evaluating recent immigrants regardless of the presence or absence of symptoms or
laboratory abnormalities.
Our study results showed that a high percentage of
recent immigrants had evidence of current or prior infection with a few key pathogenic parasites, including
S. stercoralis, Toxocara spp., and G. lamblia. Positive
serologic testing for S. stercoralis has been shown to be
associated with a high likelihood of active ongoing

Parasitol Res (2020) 119:1139–1148
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Findings associated with the presence of a parasitic infection

Demographics

Length of time living in the USA, N (%)
> 2 years
< 2 years
Mean age (standard deviation)
Gender, N (%)
Female
Male
Childhood exposures (in country of origin),
number of respondents reporting exposure (%)
Self-reported history of seeing worms in the stool
Raised in rural environment
Laboratory results
IgE, number elevatedc (%)
AEC, number elevatedd (%)
Blastocystis hominis cysts
present on O&P exam

Uninfected
N = 110

Parasitic infectiona
N = 15

Prevalence ratiob
(95% confidence interval)

P value

40 (36.4)
70 (63.6)
31 (16.4)

1 (6.7)
14 (93.3)
37.5 (21.6)

Reference
6.8 (0.9–50.2)
1.0 (1.0–1.1)

0.02

58 (52.7)
52 (47.3)

8 (53.3)
7 (46.7)

Reference
1.0 (0.4–2.5)

0.99

18 (16.4)
19 (17.3)

8 (53.3)
3 (20)

4.4 (1.7–10.9)
1.2 (0.4–3.8)

0.003
0.73

22 (20)
9 (8.3)e
5 (5.1f)

7 (46.7)
3 (20)
5 (38.5g)

3.5 (1.4–8.8)
2.4 (0.8–7.2)
6.3 (2.5–15.7)

0.04
0.2
0.002

0.2

N number of subjects
a

Not including nonpathogenic or disputed pathogenicity organisms

b

Prevalence ratio comparing the frequency of the listed demographic variable, symptom, or exposure in those with versus those without evidence of a
parasitic infection
c

Normal value of IgE < 696 IU/mL for subjects 10–12 years old, < 629 for those ages 13–15, < 537 for those ages 16–17, and < 214 IU/mL in adults

d

Normal AEC < 500 cells/UL

e

Of 108 subjects in the uninfected group who were tested for a CBC (as for 2 patients who underwent a blood draw, the CBC was unable to be performed
due to clotting of blood in the tube)

f

Of 98 subjects in the uninfected group who provided a stool sample for O&P exam

g

Of 13 subjects in this group who provided a stool sample for O&P exam

infection and risk for developing hyperinfection syndrome
(Posey et al. 2007; Vadlamudi et al. 2006). The rate of
seropositivity for strongyloidiasis in our sample was 4%.
This may have clinical implications because a study evaluating the cost-effectiveness of empiric treatment versus a
test-and-treat strategy found that if the prevalence of
Strongyloides infection is greater than 2% in a community, then the presumptive treatment strategy is more costeffective (Muennig et al. 2004). However, whether this
strategy would still be cost-effective today is not clear
and merits further study. Additionally, in areas with a
large number of West African immigrants, this treatment
strategy would not be possible due to concerns of coinfection with Loa loa.
Our results highlight the limitations of current diagnostic
tests for parasitic infections. For example, the sensitivity of
O&P exam compared to qPCR testing (which is not yet universally available) for pathogenic parasites was very poor.
While this could represent false positive qPCR tests, previous
use of these tests in other studies has indicated a low rate of
false positives (Cimino et al. 2015; Hochberg et al. 2011;
Mejia et al. 2013; Winsberg et al. 1975). An additional

limitation of diagnostics for parasites is that, for many parasitic infections, serologic testing is the primary commercially
available means of diagnosis. Positive serologic testing is not
proof of an active infection, so the utility of this information in
treating an individual patient is limited.
Similar to prior studies of immigrant populations
(Belhassen-Garcia et al. 2014; Schulte et al. 2002), we found
that a relatively high percent of subjects in our study had
eosinophilia and/or elevated IgE levels. IgE appeared to be a
slightly better marker for chronic parasitic infection in this
sample than eosinophilia. Prior studies have shown that for
some parasites (such as Toxocara), specific anti-parasite IgE
may be an even better diagnostic marker (Magnaval et al.
2006). However, neither the AEC nor the IgE had an adequate
sensitivity to merit recommending their use for routine screening purposes. Although eosinophilia has long been thought of
as a hallmark of helminth infection, several previous studies
have also failed to show any correlation between the two
(Asgary et al. 2011; Dawson-Hahn et al. 2010).
A large number of subjects in our study demonstrated
cysts of B. hominis on O&P exam. The association between B. hominis and clinical disease has been
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controversial. Various studies have shown that subjects
with B. hominis may have an increased likelihood of irritable bowel syndrome and that symptomatic patients with
this parasite may experience a beneficial effect from treatment with antiparasitic medications (Andersen and
Stensvold 2016; Coyle et al. 2012). In our study, however,
infection with B. hominis was not associated with any
increase in symptoms. Interestingly, though, subjects with
B. hominis cysts on O&P exam were more likely to also
test positive for pathogenic parasitic infections. Therefore,
our results agree with those of several recent studies and
suggest that the primary import of B. hominis infection
may be serving as a surrogate marker for the presence
of fecal-oral transmission (Coyle et al. 2012; Roberts
et al. 2014; Turkeltaub et al. 2015).
Our study had several limitations. The small number of
subjects found to have parasitic infections limited our ability
to identify risk factors associated with these infections.
However, our sample size was necessitated by the extensive
testing performed on each subject and was also similar to
those of previous studies of immigrant health (Hochberg
et al. 2011; Loutfy et al. 2002). Furthermore, the fact that
our sample was very heterogeneous and subjects enrolled in
the study came from many different countries could have reduced our ability to find associations between clinical factors
and the presence of infection. We chose to include subjects
from many different countries because the goal of the study
was to evaluate if parasitic infections are a potential health
problem within immigrant communities in general.
Our study is one of the only recent studies to evaluate if
parasitic infections currently pose health threats among immigrant communities. Our results provide an argument for further investigation of the health impacts of these infections in
the immigrant community. Although our sample size was limited, a strength of our study is that we conducted a comprehensive evaluation for parasitic infections including testing of
both stool and serum samples with novel molecular tests. Our
results suggest that as many as 12% of recent immigrants in
the community may have evidence of current or previous infection with a pathogenic parasitic species. From a public
health perspective, it is important to note that the infections
identified in the current patient sample are not typically spread
from person to person. If confirmed in a larger study, these
results present an important health disparity among a vulnerable underserved population in the USA. This health disparity
has persisted despite the presence of effective, safe, and welltolerated antiparasitic medications capable of treating each of
the identified pathogens in our sample (Muennig et al. 2004;
Posey et al. 2007).
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